Tamsin Dewé
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tamsin Dewé has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- April Lawson
2department of Equine Clinical Science, Institute of Infection, Veterinary and Ecological Sciences, School of Veterinary Science, Leahurst Campus, University Of Liverpool, Neston, United Kingdom
2 shared publications Dorina Timofte
Department of Veterinary Anatomy, Physiology and Pathology, Institute of Infection, Veterinary and Ecological Sciences, School of Veterinary Science, Leahurst Campus, University of Liverpool, Neston, United Kingdom
2 shared publications- Flavia Zendri
University of Liverpool Institute of Infection Veterinary and Ecological Sciences
2 shared publications - Gina Pinchbeck
Department of Livestock and One Health, Institute of Infection, Veterinary and Ecological Sciences, School of Veterinary Science, Leahurst Campus, University Of Liverpool, Neston, United Kingdom
2 shared publications - Leo Singer
Research and Impact Directorate, Faculty of Health and Life Sciences, University Of Liverpool, Liverpool, United Kingdom
2 shared publications A. Hanna
Animal and Plant Health Agency , New Haw, Surrey, UK
1 shared publication
Latest Publications
- Open Access
- 22 April 2026
- Published by Microbiology Society
- p. 001205.v2
An insight into Antimicrobial Resistance Screening in Veterinary Microbiology Diagnostic Laboratories in the United Kingdom
Introduction: Antimicrobial resistance (AMR) is a globally relevant public health priority requiring coordinated One Health responses. In recent years, the emergence of novel AMR phenotypes and increasing AMR trends in bacteria from companion animal and horses have become an apparent concern worldwide; nevertheless, limited national resistance monitoring programmes in Europe systematically collect and analyse data from companion animal and equine infections. In the UK, private veterinary microbiology diagnostic laboratories hold valuable AMR data, however, there is a lack of alignment in the methodologies used by diagnostic laboratories to generate these data. Gap Statement: Substantial knowledge gaps exist in the current landscape of veterinary microbiological diagnostic testing approaches for AMR in companion animals and horses. The VetCLIN AMR initiative aims to engage with UK veterinary diagnostic laboratories to capture methods used for generating routine antimicrobial susceptibility data which impacts on national AMR surveillance. Aim: To perform a UK-wide survey of veterinary laboratories processing companion animal and equine specimens evaluating the standard practices used for microbiology testing with a focus on AMR screening. Methodology: An online survey targeting veterinary diagnostic laboratories in the UK processing clinical specimens from companion animals and horses. Results: Twenty-one (n=21) UK veterinary microbiology laboratories responded, comprising commercial (10/21), university (7/21), and in-house veterinary practice/hospital laboratories (4/21). Methodological heterogeneity in bacterial identification, antimicrobial susceptibility testing (AST), AMR detection and reporting was identified across UK veterinary laboratories. Overall, the laboratories’ preferred AST method was minimum inhibitory concentration (43%), with most of these using the VITEK-1/VITEK-2 system (52%). A combination of CLSI and EUCAST standards was most used by these laboratories (62%) for AST interpretation, with limited adoption of the lower clinical breakpoints for Enterobacterales (amoxicillin–clavulanic acid and fluoroquinolones). Detection of AMR mechanisms was focused on clinical guidance and phenotypes commonly encountered among companion and equine isolates, such as screening for methicillin resistance in staphylococci (95%) and extended-spectrum beta-lactamase (ESBL)-production in Enterobacterales (48%). Up to 30% of UK veterinary laboratories screened for carbapenem resistance in Gram-negative bacteria. Detected AMR phenotypes are infrequently characterised or referred to reference laboratories and, in the case of carbapenem resistance, these are often not reported to clinicians. Conclusion: This study identified a variety of workflows used by veterinary diagnostic laboratories for bacterial identification, methodologies and interpretative criteria used for performing and reporting AST, as well as AMR screening approaches. Several gaps hindering national AMR surveillance in dogs, cats and horses in the UK have become evident. Strengthening surveillance capacity should prioritise consistent screening and characterisation of AMR mechanisms such as ESBL and carbapenemase production, to enable effective responses to AMR emergence and spread in companion animals and equine clinical infections.
- 22 April 2026
- Published by Microbiology Society
- p. 001205.v2
Open AccessAn insight into Antimicrobial Resistance Screening in Veterinary Microbiology Diagnostic Laboratories in the United Kingdom
Introduction: Antimicrobial resistance (AMR) is a globally relevant public health priority requiring coordinated One Health responses. In recent years, the emergence of novel AMR phenotypes and increasing AMR trends in bacteria from companion animal and horses have become an apparent concern worldwide; nevertheless, limited national resistance monitoring programmes in Europe systematically collect and analyse data from companion animal and equine infections. In the UK, private veterinary microbiology diagnostic laboratories hold valuable AMR data, however, there is a lack of alignment in the methodologies used by diagnostic laboratories to generate these data. Gap Statement: Substantial knowledge gaps exist in the current landscape of veterinary microbiological diagnostic testing approaches for AMR in companion animals and horses. The VetCLIN AMR initiative aims to engage with UK veterinary diagnostic laboratories to capture methods used for generating routine antimicrobial susceptibility data which impacts on national AMR surveillance. Aim: To perform a UK-wide survey of veterinary laboratories processing companion animal and equine specimens evaluating the standard practices used for microbiology testing with a focus on AMR screening. Methodology: An online survey targeting veterinary diagnostic laboratories in the UK processing clinical specimens from companion animals and horses. Results: Twenty-one (n=21) UK veterinary microbiology laboratories responded, comprising commercial (10/21), university (7/21), and in-house veterinary practice/hospital laboratories (4/21). Methodological heterogeneity in bacterial identification, antimicrobial susceptibility testing (AST), AMR detection and reporting was identified across UK veterinary laboratories. Overall, the laboratories’ preferred AST method was minimum inhibitory concentration (43%), with most of these using the VITEK-1/VITEK-2 system (52%). A combination of CLSI and EUCAST standards was most used by these laboratories (62%) for AST interpretation, with limited adoption of the lower clinical breakpoints for Enterobacterales (amoxicillin–clavulanic acid and fluoroquinolones). Detection of AMR mechanisms was focused on clinical guidance and phenotypes commonly encountered among companion and equine isolates, such as screening for methicillin resistance in staphylococci (95%) and extended-spectrum beta-lactamase (ESBL)-production in Enterobacterales (48%). Up to 30% of UK veterinary laboratories screened for carbapenem resistance in Gram-negative bacteria. Detected AMR phenotypes are infrequently characterised or referred to reference laboratories and, in the case of carbapenem resistance, these are often not reported to clinicians. Conclusion: This study identified a variety of workflows used by veterinary diagnostic laboratories for bacterial identification, methodologies and interpretative criteria used for performing and reporting AST, as well as AMR screening approaches. Several gaps hindering national AMR surveillance in dogs, cats and horses in the UK have become evident. Strengthening surveillance capacity should prioritise consistent screening and characterisation of AMR mechanisms such as ESBL and carbapenemase production, to enable effective responses to AMR emergence and spread in companion animals and equine clinical infections.
- Open Access
- 31 March 2026
- Published by Microbiology Society
- p. 001205.v1
An insight into Antimicrobial Resistance Screening in Veterinary Microbiology Diagnostic Laboratories in the United Kingdom
Introduction: Antimicrobial resistance (AMR) is a globally relevant public health priority requiring coordinated One Health responses. In recent years, the emergence of novel AMR phenotypes and increasing AMR trends in bacteria from companion animal and horses have become an apparent concern worldwide; nevertheless, limited national resistance monitoring programmes in Europe systematically collect and analyse data from companion animal and equine infections. In the UK, private veterinary microbiology diagnostic laboratories hold valuable AMR data, however, there is a lack of alignment in the methodologies used by diagnostic laboratories to generate these data. Gap Statement: Substantial knowledge gaps exist in the current landscape of veterinary microbiological diagnostic testing approaches for AMR in companion animals and horses. The VetCLIN AMR initiative aims to engage with UK veterinary diagnostic laboratories to capture methods used for generating routine antimicrobial susceptibility data which impacts on national AMR surveillance. Aim: To perform a UK-wide survey of veterinary laboratories processing companion animal and equine specimens evaluating the standard practices used for microbiology testing with a focus on AMR screening. Methodology: An online survey targeting veterinary diagnostic laboratories in the UK processing clinical specimens from companion animals and horses. Results: Twenty-one (n=21) UK veterinary microbiology laboratories responded, comprising commercial (10/21), university (7/21), and in-house veterinary practice/hospital laboratories (4/21). Methodological heterogeneity in bacterial identification, antimicrobial susceptibility testing (AST), AMR detection and reporting was identified across UK veterinary laboratories. Overall, the laboratories’ preferred AST method was minimum inhibitory concentration (43%), with most of these using the VITEK-1/VITEK-2 system (52%). A combination of CLSI and EUCAST standards was most used by these laboratories (62%) for AST interpretation, with limited adoption of the lower clinical breakpoints for Enterobacterales (amoxicillin–clavulanic acid and fluoroquinolones). Detection of AMR mechanisms was focused on clinical guidance and phenotypes commonly encountered among companion and equine isolates, such as screening for methicillin resistance in staphylococci (95%) and extended-spectrum beta-lactamase (ESBL)-production in Enterobacterales (48%). Up to 30% of UK veterinary laboratories screened for carbapenem resistance in Gram-negative bacteria. Detected AMR phenotypes are infrequently characterised or referred to reference laboratories and, in the case of carbapenem resistance, these are often not reported to clinicians. Conclusion: This study identified a variety of workflows used by veterinary diagnostic laboratories for bacterial identification, methodologies and interpretative criteria used for performing and reporting AST, as well as AMR screening approaches. Several gaps hindering national AMR surveillance in dogs, cats and horses in the UK have become evident. Strengthening surveillance capacity should prioritise consistent screening and characterisation of AMR mechanisms such as ESBL and carbapenemase production, to enable effective responses to AMR emergence and spread in companion animals and equine clinical infections.
- 31 March 2026
- Published by Microbiology Society
- p. 001205.v1
Open AccessAn insight into Antimicrobial Resistance Screening in Veterinary Microbiology Diagnostic Laboratories in the United Kingdom
Introduction: Antimicrobial resistance (AMR) is a globally relevant public health priority requiring coordinated One Health responses. In recent years, the emergence of novel AMR phenotypes and increasing AMR trends in bacteria from companion animal and horses have become an apparent concern worldwide; nevertheless, limited national resistance monitoring programmes in Europe systematically collect and analyse data from companion animal and equine infections. In the UK, private veterinary microbiology diagnostic laboratories hold valuable AMR data, however, there is a lack of alignment in the methodologies used by diagnostic laboratories to generate these data. Gap Statement: Substantial knowledge gaps exist in the current landscape of veterinary microbiological diagnostic testing approaches for AMR in companion animals and horses. The VetCLIN AMR initiative aims to engage with UK veterinary diagnostic laboratories to capture methods used for generating routine antimicrobial susceptibility data which impacts on national AMR surveillance. Aim: To perform a UK-wide survey of veterinary laboratories processing companion animal and equine specimens evaluating the standard practices used for microbiology testing with a focus on AMR screening. Methodology: An online survey targeting veterinary diagnostic laboratories in the UK processing clinical specimens from companion animals and horses. Results: Twenty-one (n=21) UK veterinary microbiology laboratories responded, comprising commercial (10/21), university (7/21), and in-house veterinary practice/hospital laboratories (4/21). Methodological heterogeneity in bacterial identification, antimicrobial susceptibility testing (AST), AMR detection and reporting was identified across UK veterinary laboratories. Overall, the laboratories’ preferred AST method was minimum inhibitory concentration (43%), with most of these using the VITEK-1/VITEK-2 system (52%). A combination of CLSI and EUCAST standards was most used by these laboratories (62%) for AST interpretation, with limited adoption of the lower clinical breakpoints for Enterobacterales (amoxicillin–clavulanic acid and fluoroquinolones). Detection of AMR mechanisms was focused on clinical guidance and phenotypes commonly encountered among companion and equine isolates, such as screening for methicillin resistance in staphylococci (95%) and extended-spectrum beta-lactamase (ESBL)-production in Enterobacterales (48%). Up to 30% of UK veterinary laboratories screened for carbapenem resistance in Gram-negative bacteria. Detected AMR phenotypes are infrequently characterised or referred to reference laboratories and, in the case of carbapenem resistance, these are often not reported to clinicians. Conclusion: This study identified a variety of workflows used by veterinary diagnostic laboratories for bacterial identification, methodologies and interpretative criteria used for performing and reporting AST, as well as AMR screening approaches. Several gaps hindering national AMR surveillance in dogs, cats and horses in the UK have become evident. Strengthening surveillance capacity should prioritise consistent screening and characterisation of AMR mechanisms such as ESBL and carbapenemase production, to enable effective responses to AMR emergence and spread in companion animals and equine clinical infections.
- 5 June 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 80 (7) , 1902-1906
Decreasing antimicrobial resistance in representative UK livestock species was associated with reduced total sales of antimicrobials in the last decade
Background: Antimicrobial resistance (AMR) in pathogenic bacteria is a leading global health crisis estimated to currently contribute to human mortality on a par with malaria or HIV, with potential to increase in importance. Livestock can comprise a reservoir of AMR, which can be directly or indirectly transmitted to humans and vice versa. Representative surveillance schemes for antimicrobial use (AMU) and AMR in livestock populations have been running in the UK since 2014, during which time veterinary AMU has decreased, providing an opportunity to assess and quantify the potential relationship between AMU and AMR. Objectives: To analyse associations between the decrease of total sales of antimicrobials for livestock and the prevalence of non-wild type (WT) (AMR) Escherichia coli detected in UK pigs and poultry in 2 year weighted data points from 2014 to 2021. Methods: AMR was measured with epidemiological cut-off values (ECOFFs). Associations between prevalence of AMR, multidrug resistance (non-WT phenotypes to three or more classes of antimicrobials), (indicator measures of AMR), and standardized veterinary antimicrobial sales were modelled by regression. Results: The decrease in any detectable AMR phenotypes in E. coli (primary indicator) was associated with the decrease of total sales of antimicrobials from 59.27 mg/population correction unit (PCU) in 2014–15 to 29.14 in 2020–21 (OR: 2.69, P < 0.001). Furthermore, prevalence of E. coli displaying multidrug resistance (secondary indicator) was also associated with the decrease in sales of antimicrobials (OR: 2.58, P < 0.001). Conclusions: The decrease in sales of antimicrobials in livestock was associated with a decrease in non-WT E. coli found in livestock.
- 5 June 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 80 (7) , 1902-1906
Decreasing antimicrobial resistance in representative UK livestock species was associated with reduced total sales of antimicrobials in the last decade
Background: Antimicrobial resistance (AMR) in pathogenic bacteria is a leading global health crisis estimated to currently contribute to human mortality on a par with malaria or HIV, with potential to increase in importance. Livestock can comprise a reservoir of AMR, which can be directly or indirectly transmitted to humans and vice versa. Representative surveillance schemes for antimicrobial use (AMU) and AMR in livestock populations have been running in the UK since 2014, during which time veterinary AMU has decreased, providing an opportunity to assess and quantify the potential relationship between AMU and AMR. Objectives: To analyse associations between the decrease of total sales of antimicrobials for livestock and the prevalence of non-wild type (WT) (AMR) Escherichia coli detected in UK pigs and poultry in 2 year weighted data points from 2014 to 2021. Methods: AMR was measured with epidemiological cut-off values (ECOFFs). Associations between prevalence of AMR, multidrug resistance (non-WT phenotypes to three or more classes of antimicrobials), (indicator measures of AMR), and standardized veterinary antimicrobial sales were modelled by regression. Results: The decrease in any detectable AMR phenotypes in E. coli (primary indicator) was associated with the decrease of total sales of antimicrobials from 59.27 mg/population correction unit (PCU) in 2014–15 to 29.14 in 2020–21 (OR: 2.69, P < 0.001). Furthermore, prevalence of E. coli displaying multidrug resistance (secondary indicator) was also associated with the decrease in sales of antimicrobials (OR: 2.58, P < 0.001). Conclusions: The decrease in sales of antimicrobials in livestock was associated with a decrease in non-WT E. coli found in livestock.
- Open Access
- 1 January 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 102, 463-471
Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China
- 1 January 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 102, 463-471
Open AccessDatabase of epidemic trends and control measures during the first wave of COVID-19 in mainland China
- Open Access
- 14 October 2019
- Published by Microbiology Society in Microbial Genomics
- Vol. 5 (10) , e000305
Genomic epidemiology of penicillin-non-susceptible Streptococcus pneumoniae
Penicillin-non-susceptible Streptococcus pneumoniae (PNSP) were first detected in the 1960s, and are now common worldwide, predominantly through the international spread of a limited number of strains. Extant PNSP are characterized by mosaic pbp2x, pbp2b and pbp1a genes generated by interspecies recombinations, with the extent of these alterations determining the range and concentrations of β-lactams to which the genotype is non-susceptible. The complexity of the genetics underlying these phenotypes has been the subject of both molecular microbiology and genome-wide association and epistasis analyses. Such studies can aid our understanding of PNSP evolution and help improve the already highly-performing bioinformatic methods capable of identifying PNSP from genomic surveillance data.
- 14 October 2019
- Published by Microbiology Society in Microbial Genomics
- Vol. 5 (10) , e000305
Open AccessGenomic epidemiology of penicillin-non-susceptible Streptococcus pneumoniae
Penicillin-non-susceptible Streptococcus pneumoniae (PNSP) were first detected in the 1960s, and are now common worldwide, predominantly through the international spread of a limited number of strains. Extant PNSP are characterized by mosaic pbp2x, pbp2b and pbp1a genes generated by interspecies recombinations, with the extent of these alterations determining the range and concentrations of β-lactams to which the genotype is non-susceptible. The complexity of the genetics underlying these phenotypes has been the subject of both molecular microbiology and genome-wide association and epistasis analyses. Such studies can aid our understanding of PNSP evolution and help improve the already highly-performing bioinformatic methods capable of identifying PNSP from genomic surveillance data.
- Open Access
- 1 September 2015
- Published by The Royal Society in Royal Society Open Science
- Vol. 2 (9) , 150173
Modelling the species jump: towards assessing the risk of human infection from novel avian influenzas
The scientific understanding of the driving factors behind zoonotic and pandemic influenzas is hampered by complex interactions between viruses, animal hosts and humans. This complexity makes identifying influenza viruses of high zoonotic or pandemic risk, before they emerge from animal populations, extremely difficult and uncertain. As a first step towards assessing zoonotic risk of influenza, we demonstrate a risk assessment framework to assess the relative likelihood of influenza A viruses, circulating in animal populations, making the species jump into humans. The intention is that such a risk assessment framework could assist decision-makers to compare multiple influenza viruses for zoonotic potential and hence to develop appropriate strain-specific control measures. It also provides a first step towards showing proof of principle for an eventual pandemic risk model. We show that the spatial and temporal epidemiology is as important in assessing the risk of an influenza A species jump as understanding the innate molecular capability of the virus. We also demonstrate data deficiencies that need to be addressed in order to consistently combine both epidemiological and molecular virology data into a risk assessment framework.
- 1 September 2015
- Published by The Royal Society in Royal Society Open Science
- Vol. 2 (9) , 150173
Open AccessModelling the species jump: towards assessing the risk of human infection from novel avian influenzas
The scientific understanding of the driving factors behind zoonotic and pandemic influenzas is hampered by complex interactions between viruses, animal hosts and humans. This complexity makes identifying influenza viruses of high zoonotic or pandemic risk, before they emerge from animal populations, extremely difficult and uncertain. As a first step towards assessing zoonotic risk of influenza, we demonstrate a risk assessment framework to assess the relative likelihood of influenza A viruses, circulating in animal populations, making the species jump into humans. The intention is that such a risk assessment framework could assist decision-makers to compare multiple influenza viruses for zoonotic potential and hence to develop appropriate strain-specific control measures. It also provides a first step towards showing proof of principle for an eventual pandemic risk model. We show that the spatial and temporal epidemiology is as important in assessing the risk of an influenza A species jump as understanding the innate molecular capability of the virus. We also demonstrate data deficiencies that need to be addressed in order to consistently combine both epidemiological and molecular virology data into a risk assessment framework.
- 1 April 2014
- Published by Elsevier in Food Control
- Vol. 38, 96-103
A qualitative risk assessment for visual-only post-mortem meat inspection of cattle, sheep, goats and farmed/wild deer
- 1 April 2014
- Published by Elsevier in Food Control
- Vol. 38, 96-103
A qualitative risk assessment for visual-only post-mortem meat inspection of cattle, sheep, goats and farmed/wild deer